Senti Biosciences
(NASDAQ) SNTI
Senti Biosciences Financials at a Glance
Market Cap
$30.07M
Revenue (TTM)
$38.00K
Net Income (TTM)
-$51.55M
EPS (TTM)
-$1.92
P/E Ratio
-0.50
Dividend
$0.00
Beta (Volatility)
3.02 (High)
Dividend
$0.00
Beta (Volatility)
3.02 (High)
Price
$0.98
Volume
225,637
Open
$0.97
Price
$0.98
Volume
225,637
Open
$0.97
Previous Close
$0.97
Daily Range
$0.94 - $1.00
52-Week Range
$0.86 - $1.10
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
3.02 (High)
Price
$0.98
Volume
225,637
Open
$0.97
Previous Close
$0.97
Daily Range
$0.94 - $1.00
52-Week Range
$0.86 - $1.10
Estimated Earnings Date
Aug 6, 2026
SNTI News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Senti Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
39
CEO
Timothy K. Lu, MD, PhD
Headquarters
South San Francisco, CA 94080, US
SNTI Financials
Key Financial Metrics (TTM)
Gross Margin
-61%
Operating Margin
-1548%
Net Income Margin
-1357%
Return on Equity
-255%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-2.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$30.07M
Shares Outstanding
31.14M
Volume
225.64K
Avg. Volume
208.47K
Financials (TTM)
Gross Profit
-$3.62M
Operating Income
-$63.73M
EBITDA
-$60.09M
Operating Cash Flow
-$43.44M
Capital Expenditure
-$196.00K
Free Cash Flow
-$43.64M
Cash & ST Invst.
$16.42M
Total Debt
$28.89M
Senti Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.00K
N/A
Gross Profit
$16.00K
N/A
Gross Margin
100.00%
N/A
Market Cap
$30.07M
N/A
Market Cap/Employee
$884.33K
N/A
Employees
34
N/A
Net Income
-$4.22M
+70.1%
EBITDA
-$10.81M
+27.6%
Quarterly Fundamentals
Net Cash
-$10.21M
-852.1%
Accounts Receivable
$172.00K
-92.2%
Inventory
$0.00
N/A
Long Term Debt
$13.25M
-52.1%
Short Term Debt
$5.89M
+22.4%
Return on Assets
-1.35%
N/A
Return on Invested Capital
-2.45%
N/A
Free Cash Flow
-$7.48M
+46.8%
Operating Cash Flow
-$7.48M
+46.8%